Results 251 to 260 of about 188,616 (304)
Impact of neuroendocrine neoplasm-specific systemic treatments on expression and function of CXCR4 in neuroendocrine tumor cells. [PDF]
Sci RepDäubler C +9 more
europepmc +1 more source
Primary renal neuroendocrine tumor combined with horseshoe kidney: a case report and review of the literature. [PDF]
BMC UrolNi J, Wu S, Ding X, Zhou G.
europepmc +1 more source
ASO Author Reflections: Illuminating Pancreatic Neuroendocrine Tumor Biology Through Real-Time Murine Modeling. [PDF]
Ann Surg OncolGao T, Hong YK.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Gastroenterology Clinics of North America, 2016
Neuroendocrine tumors are increasingly diagnosed, either incidentally as part of screening processes, or for symptoms, which have commonly been mistaken for other disorders initially. The diagnostic workup to characterize tumor behaviour and prognosis focuses on histologic, anatomic, and functional imaging assessments. Several therapeutic options exist
Basuroy, Ron +2 more
+9 more sources
Neuroendocrine tumors are increasingly diagnosed, either incidentally as part of screening processes, or for symptoms, which have commonly been mistaken for other disorders initially. The diagnostic workup to characterize tumor behaviour and prognosis focuses on histologic, anatomic, and functional imaging assessments. Several therapeutic options exist
Basuroy, Ron +2 more
+9 more sources
Gastroenteropancreatic Neuroendocrine Tumors
Gastroenterology Clinics of North America, 2022Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are the most common type of neuroendocrine tumors and are being increasingly identified in clinical practice. The diagnosis, staging, management, and surveillance of GEP-NETs rely heavily on endoscopy, and consequently, it is important for gastroenterologists to have a solid understanding of these
Conrad J, Fernandes +3 more
openaire +2 more sources
Pancreatic neuroendocrine tumors
Current Problems in Surgery, 2013Pancreatic neuroendocrine tumors (PNETs) have an incidence of approximately 1 per 100,000 individuals per year, and account for 1–2% of all pancreatic tumors. The annual incidence in the United States is about 3.65 per 100,000 population. Although they may manifest at any age, they most often occur in the fourth to sixth decades of life. Most PNETs are
Geoffrey W, Krampitz, Jeffrey A, Norton
openaire +4 more sources